Stock price when the opinion was issued
The AI hype is way overextended, like the dotcom era. NVDA's market cap is bigger than all of France or the UK or Canada. Ridiculous. If you own it, trim and take profits. NVDA is only one component of AI with software being another. Why is NVDA soaring and the other components are lagging? Is a recipe for disaster.
It just reported a top and bottom line beat and reiterated its full-year forecast, but data centre sales came in a little light, so the stock got dinged after hours. Mostly, the stock was up 35% for the year going into the print and it was priced to be perfect. Overall, a good quarter, but didn't address the conundrum that megatech companies are getting the bang from their buck in buying NVDA stuff. China is another issue. Own this, don't trade it.
The poster child. Gone up a lot, and its valuation is probably 40x forward PE. Quite expensive, unless you believe that it can maintain the treadmill of that kind of growth. He's not saying the growth is over, just that maybe the growth slows down from here. Perhaps the valuation has to stay here while earnings catch up, or it has to come down a little bit.
See his Top Picks.
Chip business is cyclical. The downslide can be precipitated by overstocking due to high demand, and that inventory has to be worked through. China has now decided it doesn't need the H20 chip, so all that inventory is now in the supply channel.
When you're paying a high price for these companies, your expectations are for sunny days. But you have to plan for the rainy ones.
Forecasting NVDA's movement after it reports late Tuesday, based on calls and puts, the share price will swing 11% either way from today's price. That straddle position is the risk that they market makers are willing to sell those calls or puts. Looking at the NVDA chart a year ago: shares ran up to earnings, followed by a sell-off for a couple of weeks. Also, we had a big move up in the price target after beating earnings. The next report: share ran up again, NVDA beat earnings, rallied for 2 weeks to the one-year forward price, then fell and went sideways to its breakout point. The last time, it rallied to a new high, a big beat, rallied a couple weeks, then another correction. Considering the price target now at $140 and 47x PE, we'll likely see selling into the quarter. Also, there's no support 11% lower, but at the rising 200-day average of $95ish.